An Evaluation of Home-Based Telemedicine Services
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
| Condition | Intervention | Phase |
|---|---|---|
|
Congestive Heart Failure Chronic Obstructive Pulmonary Disease Diabetes |
Procedure: Home care telemedicine |
Phase 2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | An Evaluation of Home-Based Telemedicine Services |
| Estimated Enrollment: | 200 |
| Study Completion Date: | June 2004 |
| Arms | Assigned Interventions |
|---|---|
| Arm 1 | Procedure: Home care telemedicine |
Detailed Description:
Background:
Tele-home health care, which providers for video interactions between home-based veterans and home care nurses, is a potentially useful adjunct to home care services. However, few randomized trials have been conducted of this technology.
Objectives:
The primary objectives were to determine if tele-home health care patients, compared with patients receiving usual home care, have:1) higher levels of health related quality of life and home care satisfaction; 2) fewer inpatient admissions, hospital stays, and outpatient and emergency room visits; and 3) higher levels of home care access, in terms of the total number of contacts between HBPC nurses and patients.
Methods:
Patients were randomly assigned to the intervention or to the control group. Video tele-health units were installed in patient homes for the intervention group, and control group patients received usual home care services. Baseline and six month follow up surveys included questions on perceived health related quality of life and home care satisfaction. T-tests were used to compare intervention and control group members in terms of six month changes in health related quality of life and satisfaction with home care. Multivariate analyses were used to assess group differences in six month health care service use, with prior service use and survival included as covariates.
Status:
The study is completed, with a final enrollment of 37 patients. Three study manuscrip[ts have been completed (two published and one under review).
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Patients must be enrolled in the home care program at the Indianapolis VAMC and have at least: (a) 6 outpatient visits, one hospitalization, or 2 or more emergency room visits in the last twelve months, (b) a care plan specifying two or more skilled nursing visits per month, (c) an expected need for future home care visits for at least one month.
Exclusion Criteria:
Contacts and LocationsPlease refer to this study by its ClinicalTrials.gov identifier: NCT00105846
| United States, Michigan | |
| VA Ann Arbor Healthcare System, Ann Arbor, MI | |
| Ann Arbor, Michigan, United States, 48105 | |
| United States, Nebraska | |
| Richard L. Roudebush VA Medical Center, Indianapolis, IN | |
| Indianapolis, Nebraska, United States, 46202-2884 | |
| Principal Investigator: | Faith P. Hopp, PhD MA MSW | VA Ann Arbor Healthcare System, Ann Arbor, MI |
More Information
Publications:
| Responsible Party: | VA Office of Research and Development |
| ClinicalTrials.gov Identifier: | NCT00105846 History of Changes |
| Other Study ID Numbers: | TEL 20-015 |
| Study First Received: | March 17, 2005 |
| Last Updated: | April 6, 2015 |
| Health Authority: | United States: Federal Government |
Additional relevant MeSH terms:
|
Heart Failure Lung Diseases Lung Diseases, Obstructive Pulmonary Disease, Chronic Obstructive |
Heart Diseases Cardiovascular Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on September 27, 2016